20.10.2016 Views

Guideline-Stroke-2011

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

hari dan dilanjutkan dengan oral 2x1000 mg selama 3 minggu dilakukan dalam<br />

penelitian ICTUS (International Citicholin Trial in Acute <strong>Stroke</strong>, ongoing).6 Selain<br />

itu, pada penelitian yang dilakukan oleh PERDOSSI secara multisenter, pemberian<br />

Plasmin oral 3x500 mg pada 66 pasien di 6 rumah sakit pendidikan di Indonesia<br />

menunjukkan efek positif pada penderita strke akut berupa perbaikan motoric, score<br />

MRS dan Barthel index.6<br />

13. Cerebral venous sinus thrombosis (CVST)7,8,9<br />

Diagnosa CVST tetap sulit. Faktor risiko yang mendasari baru diketahui sebesar 80%.<br />

Beberapa faktor risiko sering dijumpai bersamaan. Penelitian The International Study<br />

On Cerebral Vein And Dural Sinus Thrombosis (ISCVT) mendapatkan 10 faktor<br />

risiko terbanyak, antara lain kontrasepsi oral (54,3%), trombofilia (34,1%), masa nifas<br />

(13,8%), infeksi dapat berupa infeksi SSP, infeksi organ-organ wajah, dan infeksi<br />

lainnya (12,3%), gangguan hematologi seperti anemia, trombositemia, polisitemia<br />

(12%), obat-obatan (7,5%), keganasan (7,4%), kehamilan (6,3%), presipitasi mekanik<br />

termasuk cedera kepala (4,5%), dan vaskulitis (3%). Penatalaksanaan CVST diberikan<br />

secara komprehensif, yaitu dengan terapi antitrombotik, terapi simptomatik, dan terapi<br />

penyakit dasar. Pemberian terapi UFH atau LMWH direkomendasikan untuk<br />

diberikan, walaupun terdapat infark hemoragik (AHA/ASA, Class IIa, Level of<br />

evidence B). Terapi dilanjutkan dengan antikoagulan oral diberikan selama 3-6 bulan,<br />

diikuti dengan terapi antiplatelet (AHA/ASA, Class IIa, Level of evidence C).<br />

KEPUSTAKAAN<br />

1. Hart, RG & Palacio S. Cardioembolic <strong>Stroke</strong><br />

http://www.emedicine.com/neuro/topic45.htm<br />

2. Harold P. Adams, Jr, MD, dkk. <strong>Guideline</strong>s for the Early Management of Patients<br />

With Ischemic <strong>Stroke</strong>. A Scientific Statement From the <strong>Stroke</strong> Council of the<br />

American <strong>Stroke</strong> Association. <strong>Stroke</strong>. 2003;34;1056-1083.<br />

3. AHA/ASA <strong>Guideline</strong>. <strong>Guideline</strong> for the early management of adults with<br />

ischemic stroke. <strong>Stroke</strong> 2007;38:1655-1711<br />

4. European <strong>Stroke</strong> Organization. ESO-<strong>Guideline</strong>s for management of ischemic<br />

stroke 2008. Update Jan 2009.<br />

5. Harold Adams, MD, dkk. <strong>Guideline</strong>s for the Early Management of Patients With<br />

Ischemic <strong>Stroke</strong> 2005 <strong>Guideline</strong>s Update A Scientific Statement From the <strong>Stroke</strong><br />

Council of the American Heart Association/ American <strong>Stroke</strong> Association. <strong>Stroke</strong>.<br />

2005;36;916-923.<br />

6. International Citicoline on Acute <strong>Stroke</strong>: ICTUS, October 2006.<br />

7. Einhaulp K., Bousser MG, de Bruijn SFTM, Ferro JM, Martinelli, Masuhr F, et al.<br />

EFNS guideline on the treatment of cerebral venous and sinus thrombosis.<br />

European Journal of Neurology 3006, 13: 553-559.<br />

78

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!